Factorial study of moxibustion in treatment of diarrhea-predominant irritable bowel syndrome

World Journal of Gastroenterology

Volumn 20, Issue 37, 2014, Pages 13563-13572

  Zhao, Ji Meng ^a   Wu, Lu Yi ^a   Liu, Hui Rong ^b   Hu, Hong Yi ^a   Wang, Jia Ying ^a,c   Huang, Ren Jia ^a   Shi, Yin ^b   Tao, Shan Ping ^d   Gao, Qiang ^e   Zhou, Ci Li ^b   Qi, Li ^a   Ma, Xiao Peng ^b   Wu, Huan Gan ^b  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b SHANGHAI RESEARCH INSTITUTE OF ACUPUNCTURE AND MERIDIAN   (China)

^c Shanxi Province Hospital of Traditional Chinese Medicine   (China)

^d Traditional Chinese Medicine Hospital of Jiading District of Shanghai   (China)

^e Central Hospital of Shanghai Jiading District   (China)

Author keywords

Aconite cake separated moxibustion; Clinical research; Diarrhea predominant irritable bowel syndrome; Factorial design; Moxibustion quantity

Indexed keywords

ACONITE CAKE SEPARATED MOXIBUSTION; ADULT; ARTICLE; BIRMINGHAM IRRITABLE BOWEL SYNDROME SYMPTOM QUESTIONNAIRE; CONTROLLED STUDY; DIARRHEA PREDOMINANT IRRITABLE BOWEL SYNDROME; FACTORIAL DESIGN; FEMALE; HAMILTON ANXIETY SCALE; HAMILTON SCALE; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; MOXIBUSTION; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; QUALITY OF LIFE; QUALITY OF LIFE SCALE; RANDOMIZED CONTROLLED TRIAL; SELF-RATING ANXIETY SCALE; SELF-RATING DEPRESSION SCALE; TREATMENT DURATION; TREATMENT OUTCOME; CHINA; COMPARATIVE STUDY; COMPLICATION; DIARRHEA; IRRITABLE BOWEL SYNDROME; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGY; QUESTIONNAIRE; TIME;

CHINA; DIARRHEA; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; MOXIBUSTION; QUALITY OF LIFE; QUESTIONNAIRES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84910007029     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i37.13563     Document Type: Article

References (42)

1. Spiller R. Recent advances in understanding the role of serotonin in gastrointestinal motility in functional bowel disorders: alterations in 5-HT signalling and metabolism in human disease. Neurogastroenterol Motil 2007; 19 Suppl 2: 25-31 [PMID: 17620085 DOI: 10.1111/j.1365-2982.2007.00965.x]
2. Brooks JC, Zambreanu L, Godinez A, Craig AD, Tracey I. Somatotopic organisation of the human insula to painful heat studied with high resolution functional imaging. Neuroimage 2005; 27: 201-209 [PMID: 15921935]
3. Apkarian AV, Bushnell MC, Treede RD, Zubieta JK. Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain 2005; 9: 463-484 [PMID: 15979027 DOI: 10.1016/j.ejpain.2004.11.001]
4. Ochsner KN, Ludlow DH, Knierim K, Hanelin J, Ramachandran T, Glover GC, Mackey SC. Neural correlates of individual differences in pain-related fear and anxiety. Pain 2006; 120: 69-77 [PMID: 16364548 DOI: 10.1016/j.pain.2005.10.014]
5. Pan G, Lu S, Ke M, Han S, Guo H, Fang XC. An epidemiologic study of irritable bowel syndrome in Beijing-a stratified randomized study by clustering sampling. Zhonghua Liuxingbingxue Zazhi 2000; 21: 26-29[PMID: 11860753]
6. Carmona-Sánchez R, Tostado-Fernández FA. Prevalence of use of alternative and complementary medicine in patients with irritable bowel syndrome, functional dyspepsia and gastroesophageal reflux disease. Rev Gastroenterol Mex 2005; 70: 393-398 [PMID: 17058977]
7. Park JW, Lee BH, Lee H. Moxibustion in the management of irritable bowel syndrome: systematic review and metaanalysis. BMC Complement Altern Med 2013; 13: 247 [PMID: 24088418 DOI: 10.1186/1472-6882-13-247]
8. Lee J, Yoon SW. Efficacy and Safety of Moxibustion for Relieving Pain in Patients With Metastatic Cancer: A Pilot, Randomized, Single-Blind, Sham-Controlled Trial. Integr Cancer Ther 2013; 13: 211-216 [PMID: 24282101]
9. Gao X, Xu C, Wang P, Ren S, Zhou Y, Yang X, Gao L. Curative effect of acupuncture and moxibustion on insomnia: a randomized clinical trial. J Tradit Chin Med 2013; 33: 428-432 [PMID: 24187860 DOI: 10.1016/S0254-6272(13)60143-0]
10. Yan J. New breakthrough of treating bowel diseases with moxibustion, Project of technology and clinical application of treating bowel diseases with moxibustion. Zhongguo Keji Jiangli 2014; 3: 58-59
11. Wu HG, Zhao C, Shi Z, Chen HP, Liu Y, Liu SM. Clinical study on spleen-stomach-reinforcing moxibustion treatment of diarrhea-type irritable bowel syndrome. World J Acupunct-Moxibust 2002; 1: 10-15
12. Liu HR, Hua XG, Yang Y, Wu HG. Clinical study on 5-HT expression in colonic mucosa and the treatment of herbpartition moxibustion in diarrhea-predominant IBS. Liaoning Zhongyi Zazhi 2006; 33: 984-985
13. Wu LY, Bao CH, Ge LB, Zhou CL, Liu HR, Qi L, Wu HG, Wang XM. Mild moxibustion at Tianshu (ST 25) decreases expression of prokineticin-1 and prokineticin receptor-1 in colon tissue of rats with chronic visceral hyperalgesia. Neural Regen Res 2011; 6: 2600-2604 [DOI: 10.3969/j.issn.1673-5374.2011.33.007]
14. Yi T, Qi L, Wu HG, Ma XP, Liu HR, Wang XM. Analgesic action of suspended moxibustion in rats with chronic visceral hyperalgesia correlates with enkephalins in the spinal cord. Neural Regen Res 2012; 7: 219-222 [DOI: 10.3969/j.issn.1673-5374.2012.03.011]
15. Zhou EH, Liu HR, Wu HG, Shi Y, Wang XM, Tan LY, Yao LQ, Zhong YS, Jiang Y, Zhang LL. Suspended moxibustion relieves chronic visceral hyperalgesia via serotonin pathway in the colon. Neurosci Lett 2009; 451: 144-147 [PMID: 19114087 DOI: 10.1016/j.neulet.2008.12.026]
16. Liu HR, Qi L, Wu LY, Ma XP, Qin XD, Huang WY, Dong M, Wu HG. Effects of moxibustion on dynorphin and endomorphin in rats with chronic visceral hyperalgesia. World J Gastroenterol 2010; 16: 4079-4083 [PMID: 20731023 DOI: 10.3748/wjg.v16.i32.4079]
17. Zhou EH, Wang XM, Ding GH, Wu HG, Qi L, Liu HR, Zhang SJ. Suspended moxibustion relieves chronic visceral hyperalgesia and decreases hypothalamic corticotropin-releasing hormone levels. World J Gastroenterol 2011; 17: 662-665 [PMID: 21350717 DOI: 10.3748/WJG.V17.I5.662]
18. Qi L, Liu HR, Yi T, Wu LY, Liu XR, Zhao C, Shi Y, Ma XP, Wu HG. Warming Moxibustion Relieves Chronic Visceral Hyperalgesia in Rats: Relations to Spinal Dynorphin and Orphanin-FQ System. Evid Based Complement Alternat Med 2013; 2013: 920675 [PMID: 23573158 DOI: 10.1155/2013/92067]
19. Zhou EH, Liu HR, Wu HG, Shi Y, Wang XM, Yao LQ, Zhong YS, Yang Y. Herb-partition moxibustion relieves chronic visceral hyperalgesia and 5-HT concentration in colon mucosa of rats. Neurol Res 2009; 31: 734-737 [PMID: 19108755 DOI: 10.1179/174313209X382313]
20. Ma YX, Liu X, Liu CZ, Wang LP, Guo G, Du DQ, Wang ZL, Ma H, Qi P, Li ZF, Guo YP, Yi HQ, Gao SZ. Randomized clinical trial: the clinical effects of herb-partitioned moxibustion in patients with diarrhoea-predominant irritable bowel syndrome. Evid Based Complement Alternat Med 2013; 2013: 605460 [PMID: 24454500 DOI: 10.1155/2013/605460]
21. Qi L, Li N, Liu HR, Ma XP, Wu LY, Wang XM, Zhou CL, Wu HG. Clinical and experimental studies on muxibustion for treatment of irritable bowel syndrome. Zhonghua Zhongyiyao Zazhi 2010; 25: 2224-2227
22. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006; 130: 1377-1390 [PMID: 16678553 DOI: 10.1053/j.gastro.2006.03.008]
23. Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997; 11: 395-402 [PMID: 9146781 DOI: 10.1046/j.1365-2036.1997.142318000.x]
24. Roalfe AK, Roberts LM, Wilson S. Evaluation of the Birmingham IBS symptom questionnaire. BMC Gastroenterol 2008; 8: 30 [PMID: 18651941 DOI: 10.1186/1471-230X-8-30]
25. Drossman DA, Patrick DL, Whitehead WE, Toner BB, Diamant NE, Hu Y, Jia H, Bangdiwala SI. Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire. Am J Gastroenterol 2000; 95: 999-1007 [PMID: 10763950]
26. Li HY, Gao L, Li NX. Evaluation of IBS-QOL scale in irritable bowel syndrome. Zhongguo Xunzheng Yixue Zazhi 2004; 12: 875-877.
27. Zung WW, Richards CB, Short MJ. Self-rating depression scale in an outpatient clinic. Further validation of the SDS. Arch Gen Psychiatry 1965; 13: 508-515 [PMID: 4378854 DOI: 10.1001/archpsyc.1965.01730060026004]
28. Zung WW. A rating instrument for anxiety disorders. Psychosomatics 1971; 12: 371-379 [PMID: 5172928 DOI: 10.1016/S0033-3182(71)71479-0]
29. Xu J, Wei Y. Social support as a moderator of the relationship between anxiety and depression: an empirical study with adult survivors of Wenchuan earthquake. PLoS One 2013; 8: e79045 [PMID: 24250754 DOI: 10.1371/journal.pone.0079045.eCollection]
30. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6: 278-296 [PMID: 6080235 DOI: 10.1111/j.2044-8260.1967.tb00530.x]
31. Miller IW, Bishop S, Norman WH, Maddever H. The Modified Hamilton Rating Scale for Depression: reliability and validity. Psychiatry Res 1985; 14: 131-142 [PMID: 3857653 DOI: 10.1016/0165-1781(85)90057-5]
32. Maier W, Buller R, Philipp M, Heuser I. The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders. J Affect Disord 1988; 14: 61-68 [PMID: 2963053 DOI: 10.1016/0165-0327(88)90072-9]
33. Lee MS, Kang JW, Ernst E. Does moxibustion work? An overview of systematic reviews. BMC Res Notes 2010; 3: 284 [PMID: 21054851 DOI: 10.1186/1756-0500-3-284]
34. Li SJ, Su BZ. Irritable bowel syndrome investigation of psychological factors. Inner Mongolia Yixue Zazhi 2011; 43: 833-834
35. Tosic-Golubovic S, Miljkovic S, Nagorni A, Lazarevic D, Nikolic G. Irritable bowel syndrome, anxiety, depression and personality characteristics. Psychiatr Danub 2010; 22: 418-424 [PMID: 20856185]
36. Tarrerias AL, Costil V, Vicari F, Létard JC, Adenis-Lamarre P, Aisène A, Batistelli D, Bonnaud G, Carpentier S, Dalbiès P, Ecuer S, Etienne J, Fantoli M, Grunberg B, Lannoy P, Lapuelle J, Margulies A, Neumeier M, Rouillon JM, Schmets L, Pingannaud MP, Coulom P, Kholer F, Canard JM. The effect of inactivated Lactobacillus LB fermented culture medium on symptom severity: observational investigation in 297 patients with diarrhea-predominant irritable bowel syndrome. Dig Dis 2011; 29: 588-591 [PMID: 22179215 DOI: 10.1159/000332987]
37. Coffin B, Dapoigny M, Cloarec D, Comet D, Dyard F. Relationship between severity of symptoms and quality of life in 858 patients with irritable bowel syndrome. Gastroenterol Clin Biol 2004; 28: 11-15 [PMID: 15041804 DOI: 10.1016/S0399-8320(04)94834-8]
38. Sabate JM, Veyrac M, Mion F, Siproudhis L, Ducrotte P, Zerbib F, Grimaud JC, Dapoigny M, Dyard F, Coffin B. Relationship between rectal sensitivity, symptoms intensity and quality of life in patients with irritable bowel syndrome. Aliment Pharmacol Ther 2008; 28: 484-490 [PMID: 18544074 DOI: 10.111/j.1365-2036.2008.03759x]
39. Spence MJ, Moss-Morris R. The cognitive behavioural model of irritable bowel syndrome: a prospective investigation of patients with gastroenteritis. Gut 2007; 56: 1066-1071 [PMID: 17324974 DOI: 10.1136/gut.2006.108811]
40. Drossman DA, Ringel Y, Vogt BA, Leserman J, Lin W, Smith JK, Whitehead W. Alterations of brain activity associated with resolution of emotional distress and pain in a case of severe irritable bowel syndrome. Gastroenterology 2003; 124: 754-761 [PMID: 12612913 DOI: 10.1053/gast.2003.50103]
41. Morgan V, Pickens D, Gautam S, Kessler R, Mertz H. Amitriptyline reduces rectal pain related activation of the anterior cingulate cortex in patients with irritable bowel syndrome. Gut 2005; 54: 601-607 [PMID: 15831901 DOI: 10.1136/gut.2004.047423]
42. Chen YH, Chen XK, Yin XJ. [Comparison of the therapeutic effects of electroacupuncture and probiotics combined with deanxit in treating diarrhea-predominant irritable bowel syndrome]. Zhongguo Zhongxiyi Jiehe Zazhi 2012; 32: 594-598 [PMID: 22679715 DOI: 10.7661/CJIM.2012.5.594]